MASS
908 Devices Inc.
NASDAQ · Healthcare · Medical - Devices · US
$10.05
+0.10%Income statement
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue | |||||
| Total Revenue | 60.8M | 56.2M | 59.6M | 50.2M | 46.9M |
| Cost of Revenue | 30.5M | 29.4M | 29.7M | 24.9M | 20.8M |
| Gross Profit | 30.3M | 26.8M | 29.9M | 25.3M | 26.0M |
| Operating Expenses | |||||
| R&D Expense | 13.2M | 13.8M | 25.5M | 21.9M | 17.5M |
| SG&A Expense | 38.7M | 37.2M | — | — | 43.9M |
| General & Admin Expense | 11.1M | — | — | — | — |
| Selling & Marketing Expense | — | — | — | — | — |
| Other Expenses | 6.4M | — | 81.1M | 46.2M | — |
| Total Operating Expenses | 58.3M | 51.0M | 106.6M | 68.1M | 61.4M |
| Cost and Expenses | 88.8M | 80.4M | 136.3M | 93.0M | 82.2M |
| Operating Income (EBIT) | (28.0M) | (24.2M) | (76.7M) | (42.8M) | (35.4M) |
| Non-Operating | |||||
| Interest Income | 3.1M | 4.1M | 4.5M | 6.5M | 2.0M |
| Interest Expense | — | — | — | 201.0K | 129.0K |
| Net Interest Income | 3.1M | 4.1M | 4.5M | 6.3M | 1.9M |
| Other Non-Op Income/Expense | (6.5M) | (9.2M) | 4.2M | 6.1M | 1.8M |
| Non-Operating Income (excl Interest) | 6.5M | 9.2M | (28.2M) | (107.0K) | (1.9M) |
| EBT (Pre-Tax Income) | (34.5M) | (33.3M) | (72.5M) | (36.6M) | (33.6M) |
| Income Tax Expense | (191.0K) | (66.0K) | (282.0K) | (211.0K) | — |
| Bottom Line | |||||
| Net Income | (34.5M) | (36.6M) | (72.2M) | (36.4M) | (33.6M) |
| Earnings from Cont. Ops | (34.3M) | (33.3M) | (72.2M) | (36.4M) | (33.6M) |
| Earnings from Discont. Ops | (204.0K) | (3.4M) | — | — | — |
| Bottom Line Net Income | (34.5M) | (36.6M) | (72.2M) | (36.4M) | (33.6M) |
| Per Share | |||||
| Basic EPS | ($0.93) | ($1.01) | ($2.12) | ($1.13) | ($1.07) |
| Diluted EPS | ($0.95) | ($0.94) | ($2.12) | ($1.13) | ($1.07) |
| Revenue Per Share | $1.61 | $1.55 | $1.75 | $1.56 | $1.49 |
| Shares | |||||
| Basic Shares Outstanding | 37.7M | 36.2M | 34.1M | 32.2M | 31.5M |
| Diluted Shares Outstanding | 37.7M | 38.9M | 34.1M | 32.2M | 31.5M |
| Profitability Metrics | |||||
| EBITDA | (29.8M) | (28.9M) | (43.9M) | (40.3M) | (31.8M) |
| D&A | 4.7M | 4.5M | 4.7M | 2.4M | 1.6M |
| EBIT | (34.5M) | (33.3M) | (48.6M) | (42.7M) | (33.4M) |
As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Jun 1, 2026